Pheophorbide a 17-diethylene glycol
ester (XL-8), is a promising high-active derivative of known
photosensitizer chlorin e6 used in
photodynamic therapy. However, high lipophilicity and poor
tumor accumulation limit XL-8 therapeutic application. We developed a novel XL-8 loaded with
poly(D,L-lactide-co-glycolide) nanoparticles using the single
emulsion-
solvent evaporation method. The nanoparticles possessed high XL-8 loading content (4.6%) and encapsulation efficiency (87.7%) and a small size (182 ± 19 nm), and negative surface charge (-22.2 ± 3.8 mV) contributed to a specific intracellular accumulation. Sustained biphasic XL-8 release from nanoparticles enhanced the
photosensitizer photostability upon irradiation that could potentially reduce the quantity of the
drug applied. Additionally, the encapsulation of XL-8 in the
polymer matrix preserved phototoxic activity of the payload. The nanoparticles displayed enhanced cellular internalization. Flow cytometry and confocal
laser-scanning microscopy studies revealed rapid XL-8 loaded nanoparticles distribution throughout the cell and initiation of DNA damage,
glutathione depletion, and lipid peroxidation via
reactive oxygen species formation. The novel nanoformulated XL-8 simultaneously revealed a significant
phototoxicity accompanied with enhanced photostability, in contrast with traditional
photosensitizers, and demonstrated a great potential for further in vivo studies.